![T. S. Harigopal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
T. S. Harigopal
Chief Operating Officer at
IGM BIOSCIENCES, INC.
Profile
T.
S.
Harigopal currently works at IGM Biosciences, Inc., as Senior Vice President-Group Operations.
Mr. Harigopal also formerly worked at Pharmacyclics LLC, as Director-Information Technology and Cytokinetics, Inc., as Senior Director-Information Technology.
Mr. Harigopal received his Masters Business Admin degree from California State University-East Bay and undergraduate degree from the University of Mumbai.
T. S. Harigopal active positions
| Companies | Position | Start |
|---|---|---|
| IGM BIOSCIENCES, INC. | Chief Operating Officer | - |
Former positions of T. S. Harigopal
| Companies | Position | End |
|---|---|---|
| PHARMACYCLICS, INC. | Chief Tech/Sci/R&D Officer | - |
| CYTOKINETICS, INCORPORATED | Chief Tech/Sci/R&D Officer | - |
Training of T. S. Harigopal
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
28
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
California State University-East Bay
 California State University-East Bay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IGM Biosciences, Inc.
 IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients | Health Technology |
- Stock Market
- Insiders
- T. S. Harigopal
